{"recordsFiltered":48535,"recordsTotal":48535,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=33600","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=33000","results":[{"registry_id":"NCT02738606","publication_url":"https://clinicaltrials.gov/study/NCT02738606","title":"Randomized Controlled Phase II Trial of Liver Resection Versus No Surgery in Patients With Liver and Unresectable Pulmonary Metastases From Colorectal Cancer","has_exemption":false,"start_date":"2016-09-23","completion_date":"2025-12-05","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03360890","publication_url":"https://clinicaltrials.gov/study/NCT03360890","title":"Synergy of Pembrolizumab Anti-PD-1 Immunotherapy With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors. The iPRIME Study.","has_exemption":false,"start_date":"2018-03-26","completion_date":"2025-12-05","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04143711","publication_url":"https://clinicaltrials.gov/study/NCT04143711","title":"A Phase I/II, First-In-Human, Multi-Part, Open-Label, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of DF1001 in Patients With Locally Advanced or Metastatic Solid Tumors, and Expansion in Selected Indications","has_exemption":false,"start_date":"2019-11-11","completion_date":"2025-12-05","has_results":false,"results_due":false,"sponsor_name":"Dragonfly Therapeutics","sponsor_slug":"dragonfly-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04482062","publication_url":"https://clinicaltrials.gov/study/NCT04482062","title":"Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device","has_exemption":false,"start_date":"2021-04-09","completion_date":"2025-12-05","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05342636","publication_url":"https://clinicaltrials.gov/study/NCT05342636","title":"A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer naïve to PD-1/PD-L1 Treatment (KEYMAKER-U06): Substudy 06A.","has_exemption":false,"start_date":"2022-07-27","completion_date":"2025-12-05","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05630183","publication_url":"https://clinicaltrials.gov/study/NCT05630183","title":"A Randomized, Open-Label, Phase II Trial of Nab-paclitaxel + Gemcitabine With or Without Botensilimab (AGEN1181) in Patients With Metastatic Pancreatic Cancer Who Have Progressed on Prior 5FU + Leucovorin + Irinotecan + Oxaliplatin (FOLFIRINOX)","has_exemption":false,"start_date":"2023-03-27","completion_date":"2025-12-05","has_results":false,"results_due":false,"sponsor_name":"Agenus Inc.","sponsor_slug":"agenus-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05676294","publication_url":"https://clinicaltrials.gov/study/NCT05676294","title":"The Impact of Pre-operative Olanzapine on Quality of Recovery-40 Scores After Discharge From Ambulatory Surgery","has_exemption":false,"start_date":"2023-06-26","completion_date":"2025-12-05","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05194293","publication_url":"https://clinicaltrials.gov/study/NCT05194293","title":"Neoadjuvant Regorafenib Plus Durvalumab (MEDI4736) in Patients With High-Risk Hepatocellular Carcinoma","has_exemption":false,"start_date":"2023-07-01","completion_date":"2025-12-05","has_results":false,"results_due":false,"sponsor_name":"Academic and Community Cancer Research United","sponsor_slug":"academic-and-community-cancer-research-united","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06101290","publication_url":"https://clinicaltrials.gov/study/NCT06101290","title":"Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)","has_exemption":false,"start_date":"2023-10-05","completion_date":"2025-12-05","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06101277","publication_url":"https://clinicaltrials.gov/study/NCT06101277","title":"Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)","has_exemption":false,"start_date":"2023-10-05","completion_date":"2025-12-05","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06103669","publication_url":"https://clinicaltrials.gov/study/NCT06103669","title":"Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)","has_exemption":false,"start_date":"2023-10-05","completion_date":"2025-12-05","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06103682","publication_url":"https://clinicaltrials.gov/study/NCT06103682","title":"LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)","has_exemption":false,"start_date":"2023-10-05","completion_date":"2025-12-05","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06662500","publication_url":"https://clinicaltrials.gov/study/NCT06662500","title":"Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study of the Shockwave Intravascular Lithotripsy (IVL) System With the Shockwave Javelin Coronary IVL Catheter (FORWARD CAD IDE Study)","has_exemption":false,"start_date":"2025-04-04","completion_date":"2025-12-05","has_results":false,"results_due":false,"sponsor_name":"Shockwave Medical, Inc.","sponsor_slug":"shockwave-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02193282","publication_url":"https://clinicaltrials.gov/study/NCT02193282","title":"Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2015-02-11","completion_date":"2025-12-06","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04268901","publication_url":"https://clinicaltrials.gov/study/NCT04268901","title":"Effectiveness of Virtual Reality to Reduce Pain/Anxiety During Routine Painful Procedures","has_exemption":false,"start_date":"2016-02-19","completion_date":"2025-12-06","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Los Angeles","sponsor_slug":"childrens-hospital-los-angeles","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05027425","publication_url":"https://clinicaltrials.gov/study/NCT05027425","title":"Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant","has_exemption":false,"start_date":"2021-12-07","completion_date":"2025-12-07","has_results":false,"results_due":false,"sponsor_name":"Davendra Sohal","sponsor_slug":"davendra-sohal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06374225","publication_url":"https://clinicaltrials.gov/study/NCT06374225","title":"Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention (SAVE-O2 AI)","has_exemption":false,"start_date":"2024-04-29","completion_date":"2025-12-07","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02654119","publication_url":"https://clinicaltrials.gov/study/NCT02654119","title":"A Phase II Study of Adjuvant Therapy Using a Regimen of Cyclophosphamide, Paclitaxel With Trastuzumab in Stage I-II HER2/Neu Positive Breast Cancer Patients","has_exemption":false,"start_date":"2015-12-11","completion_date":"2025-12-08","has_results":true,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02452008","publication_url":"https://clinicaltrials.gov/study/NCT02452008","title":"Overcoming Drug Resistance in Metastatic Castration-resistant Prostate Cancer With Novel Combination of TGF-β Receptor Inhibitor LY2157299 and Enzalutamide: a Randomized Multi-site Phase II Study","has_exemption":false,"start_date":"2016-05-03","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04607421","publication_url":"https://clinicaltrials.gov/study/NCT04607421","title":"AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF FIRST-LINE ENCORAFENIB PLUS CETUXIMAB WITH OR WITHOUT CHEMOTHERAPY VERSUS STANDARD OF CARE THERAPY WITH A SAFETY LEAD-IN OF ENCORAFENIB AND CETUXIMAB PLUS CHEMOTHERAPY IN PARTICIPANTS WITH METASTATIC BRAF V600E-MUTANT COLORECTAL CANCER","has_exemption":false,"start_date":"2020-12-21","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05447078","publication_url":"https://clinicaltrials.gov/study/NCT05447078","title":"Impact of Oral Immulina TM on Natural Killer Cell Activities and Other Biomarkers Associated With Increasing Host Immune Resilience to Upper Respiratory Viruses in Normal Human Volunteers","has_exemption":false,"start_date":"2022-07-01","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"University of Mississippi Medical Center","sponsor_slug":"university-of-mississippi-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05190744","publication_url":"https://clinicaltrials.gov/study/NCT05190744","title":"A Multi-center, Open-Label, Exploratory Study to Assess the Efficacy of PB in Decreasing the Urine Output and Increasing the Urine Osmolality in Patients With Hereditary Nephrogenic Diabetes Insipidus, Patients With Autosomal Dominant Polycystic Kidney Disease Treated With Tolvaptan, And Severely Polyuric Patients With Previous Lithium Administration (Serendipity-PB1)","has_exemption":false,"start_date":"2022-09-01","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05763121","publication_url":"https://clinicaltrials.gov/study/NCT05763121","title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eosinophilic Asthma","has_exemption":false,"start_date":"2023-01-30","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"Areteia Therapeutics","sponsor_slug":"areteia-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05813288","publication_url":"https://clinicaltrials.gov/study/NCT05813288","title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eosinophilic Asthma","has_exemption":false,"start_date":"2023-03-27","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"Areteia Therapeutics","sponsor_slug":"areteia-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05856136","publication_url":"https://clinicaltrials.gov/study/NCT05856136","title":"Investigation of the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle to Generate Higher Force Behaviors","has_exemption":false,"start_date":"2023-06-19","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05573334","publication_url":"https://clinicaltrials.gov/study/NCT05573334","title":"Effects of Flourish HEC Vaginal Care System in Menopausal Women With Recurrent Urinary Tract Infections","has_exemption":false,"start_date":"2023-07-10","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"Vaginal Biome Science","sponsor_slug":"vaginal-biome-science","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06652568","publication_url":"https://clinicaltrials.gov/study/NCT06652568","title":"Determining the Validity of ThinkSono Guidance for Ultrasound Image Acquisition and Remote Detection","has_exemption":false,"start_date":"2023-11-08","completion_date":"2025-12-08","has_results":true,"results_due":false,"sponsor_name":"ThinkSono, Ltd.","sponsor_slug":"thinksono-ltd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06131437","publication_url":"https://clinicaltrials.gov/study/NCT06131437","title":"Efficacy and Safety of Cagrilintide 2.4 mg s.c. in Combination With Semaglutide 2.4 mg s.c. (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly Compared to Tirzepatide 15 mg s.c. Once-weekly in Participants With Obesity","has_exemption":false,"start_date":"2023-11-27","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06095531","publication_url":"https://clinicaltrials.gov/study/NCT06095531","title":"A Pilot Clinical Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive Based on Imaging and Patient Reported Outcomes","has_exemption":false,"start_date":"2024-04-18","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"RevBio","sponsor_slug":"revbio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06388889","publication_url":"https://clinicaltrials.gov/study/NCT06388889","title":"An Open-Label Long-Term Phase III Extension Study to Assess the Long-Term Safety and Tolerability of Dexpramipexole in Participants With Severe Eosinophilic Asthma","has_exemption":false,"start_date":"2024-06-12","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"Areteia Therapeutics","sponsor_slug":"areteia-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06408168","publication_url":"https://clinicaltrials.gov/study/NCT06408168","title":"Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)","has_exemption":false,"start_date":"2024-08-08","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06525935","publication_url":"https://clinicaltrials.gov/study/NCT06525935","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Once-Weekly CT-388 Administered for 48 Weeks to Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity","has_exemption":false,"start_date":"2024-08-16","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"Carmot Therapeutics, Inc.","sponsor_slug":"carmot-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07002905","publication_url":"https://clinicaltrials.gov/study/NCT07002905","title":"A Phase IIa, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity or Overweight With Weight-Related Comorbidities","has_exemption":false,"start_date":"2025-07-03","completion_date":"2025-12-08","has_results":false,"results_due":false,"sponsor_name":"Ascletis Pharma (China) Co., Limited","sponsor_slug":"ascletis-pharma-china-co-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04236908","publication_url":"https://clinicaltrials.gov/study/NCT04236908","title":"Accessible Acupuncture for the Warrior With Acute Low Back Pain","has_exemption":false,"start_date":"2020-08-25","completion_date":"2025-12-09","has_results":false,"results_due":false,"sponsor_name":"David Moss","sponsor_slug":"david-moss","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04397185","publication_url":"https://clinicaltrials.gov/study/NCT04397185","title":"Randomized Prospective Trial of Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer","has_exemption":false,"start_date":"2020-12-23","completion_date":"2025-12-09","has_results":false,"results_due":false,"sponsor_name":"CairnSurgical, Inc.","sponsor_slug":"cairnsurgical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04692597","publication_url":"https://clinicaltrials.gov/study/NCT04692597","title":"Low Level Laser Therapy (LLLT) for the Treatment of Hand Osteoarthritis.","has_exemption":false,"start_date":"2021-03-02","completion_date":"2025-12-09","has_results":false,"results_due":false,"sponsor_name":"David Moss","sponsor_slug":"david-moss","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07153991","publication_url":"https://clinicaltrials.gov/study/NCT07153991","title":"Efficacy of Donepezil in Patients With Chronic Tinnitus","has_exemption":false,"start_date":"2021-11-19","completion_date":"2025-12-09","has_results":false,"results_due":false,"sponsor_name":"University of Sao Paulo","sponsor_slug":"university-of-sao-paulo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05150652","publication_url":"https://clinicaltrials.gov/study/NCT05150652","title":"Phase 2 Study of Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer","has_exemption":false,"start_date":"2022-02-18","completion_date":"2025-12-09","has_results":false,"results_due":false,"sponsor_name":"Irada Ibrahim-zada","sponsor_slug":"irada-ibrahim-zada","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04530123","publication_url":"https://clinicaltrials.gov/study/NCT04530123","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose-Ranging Study to Evaluate the Efficacy and Safety of TAK-101 for the Prevention of Gluten-Specific T Cell Activation in Subjects With Celiac Disease on a Gluten-Free Diet","has_exemption":false,"start_date":"2022-06-23","completion_date":"2025-12-09","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05636293","publication_url":"https://clinicaltrials.gov/study/NCT05636293","title":"Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib to Prevent Gluten-induced Celiac Enteropathy and Symptoms in Celiac Disease Patients in Remission","has_exemption":false,"start_date":"2023-03-01","completion_date":"2025-12-09","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05023967","publication_url":"https://clinicaltrials.gov/study/NCT05023967","title":"Time Restricted Eating And Metformin (TEAM) in Invasive Breast Cancer (IBC) or Ductal Carcinoma in Situ (DCIS). A Randomized, Phase IIb, Window of Opportunity Presurgical Trial.","has_exemption":false,"start_date":"2023-04-04","completion_date":"2025-12-09","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06198439","publication_url":"https://clinicaltrials.gov/study/NCT06198439","title":"Higher Neural and Clinical Effects of Non-Invasive Transcranial Neuromodulation in Adults With Overactive Bladder","has_exemption":false,"start_date":"2024-01-08","completion_date":"2025-12-09","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06554873","publication_url":"https://clinicaltrials.gov/study/NCT06554873","title":"Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders","has_exemption":false,"start_date":"2024-08-29","completion_date":"2025-12-09","has_results":false,"results_due":false,"sponsor_name":"Rose Research Center, LLC","sponsor_slug":"rose-research-center-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02971748","publication_url":"https://clinicaltrials.gov/study/NCT02971748","title":"A Phase II Study of Anti-PD-1 (Pembrolizumab) in Combination With Hormonal Therapy During or After Radiation in Patients With Hormone Receptor (HR)-Positive Localized Inflammatory Breast Cancer (IBC) Who Did Not Achieve a Pathological Complete Response (pCR) to Neoadjuvant Chemotherapy","has_exemption":false,"start_date":"2017-01-26","completion_date":"2025-12-10","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03864068","publication_url":"https://clinicaltrials.gov/study/NCT03864068","title":"Inositol Supplementation to Treat Polycystic Ovary Syndrome: A Double Blind Dose Ranging RCT (INSUPP-PCOS)","has_exemption":false,"start_date":"2020-01-24","completion_date":"2025-12-10","has_results":false,"results_due":false,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04386317","publication_url":"https://clinicaltrials.gov/study/NCT04386317","title":"The Effect of a1- Adrenergic Receptor Antagonist Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease","has_exemption":false,"start_date":"2020-11-01","completion_date":"2025-12-10","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04616326","publication_url":"https://clinicaltrials.gov/study/NCT04616326","title":"A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age With Chronic Migraine - the REBUILD-2 Study","has_exemption":false,"start_date":"2020-11-25","completion_date":"2025-12-10","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05814159","publication_url":"https://clinicaltrials.gov/study/NCT05814159","title":"A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of Subcutaneous Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)","has_exemption":false,"start_date":"2022-08-24","completion_date":"2025-12-10","has_results":false,"results_due":false,"sponsor_name":"Swedish Orphan Biovitrum","sponsor_slug":"swedish-orphan-biovitrum","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04001946","publication_url":"https://clinicaltrials.gov/study/NCT04001946","title":"Clinical Trial of Gastrostomy Button Securement Device","has_exemption":false,"start_date":"2023-01-30","completion_date":"2025-12-10","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06106256","publication_url":"https://clinicaltrials.gov/study/NCT06106256","title":"3WAVeS: Three-Axis Wearable Adaptive Vestibular Stimulator","has_exemption":false,"start_date":"2023-11-15","completion_date":"2025-12-10","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06358313","publication_url":"https://clinicaltrials.gov/study/NCT06358313","title":"Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Moderate and Moderate-to-severe Stroke, a Randomized Controlled Single-blinded Trial","has_exemption":false,"start_date":"2024-04-10","completion_date":"2025-12-10","has_results":false,"results_due":false,"sponsor_name":"Kafrelsheikh University","sponsor_slug":"kafrelsheikh-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06985628","publication_url":"https://clinicaltrials.gov/study/NCT06985628","title":"Alleviating Dyspnea With Non-Invasive Neuromodulation : A Feasibility Sham-Controlled Randomized Trial","has_exemption":false,"start_date":"2024-11-18","completion_date":"2025-12-10","has_results":false,"results_due":false,"sponsor_name":"Université de Sherbrooke","sponsor_slug":"universite-de-sherbrooke","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03646461","publication_url":"https://clinicaltrials.gov/study/NCT03646461","title":"A Multi-Institutional, Open-Label, Randomized, Phase II Trial Of Ibrutinib In Combination With EGFR Inhibition Or PD-1 Inhibition In Patients With Recurrent/Metastatic Head And Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2018-10-17","completion_date":"2025-12-11","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04091022","publication_url":"https://clinicaltrials.gov/study/NCT04091022","title":"A Randomized, Placebo-controlled, Double-blind, Phase II Chemoprevention Clinical Trial of Topical Diclofenac and DFMO in Subjects With a History of Skin Cancer","has_exemption":false,"start_date":"2021-01-18","completion_date":"2025-12-11","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04838769","publication_url":"https://clinicaltrials.gov/study/NCT04838769","title":"Water Vapor Thermotherapy vs. Combination Pharmacotherapy for Symptomatic Benign Prostatic Hyperplasia Refractory to Alpha Blocker Monotherapy in Sexually Active Men: A Multicenter Randomized Controlled Trial","has_exemption":false,"start_date":"2021-09-15","completion_date":"2025-12-11","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06055244","publication_url":"https://clinicaltrials.gov/study/NCT06055244","title":"Amantadine Therapy for Cognitive Impairment Related to Post-COVID Condition","has_exemption":false,"start_date":"2023-12-07","completion_date":"2025-12-11","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06665672","publication_url":"https://clinicaltrials.gov/study/NCT06665672","title":"Effect of Vibro-acoustic Stimulation on Night Shift Worker Sleep, Alertness, and Recovery (The Sleep Vibe Study)","has_exemption":false,"start_date":"2024-11-26","completion_date":"2025-12-11","has_results":false,"results_due":false,"sponsor_name":"Daniel Patterson, PhD, NRP","sponsor_slug":"daniel-patterson-phd-nrp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03985527","publication_url":"https://clinicaltrials.gov/study/NCT03985527","title":"Transvenous Nerve Stimulation Study (Janus Study)","has_exemption":false,"start_date":"2020-01-09","completion_date":"2025-12-12","has_results":false,"results_due":false,"sponsor_name":"Respicardia, Inc.","sponsor_slug":"respicardia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04599478","publication_url":"https://clinicaltrials.gov/study/NCT04599478","title":"Pharmacological and Behavioral Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes After Bariatric Surgery: Acute (Stage 1)","has_exemption":false,"start_date":"2021-06-29","completion_date":"2025-12-12","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06066528","publication_url":"https://clinicaltrials.gov/study/NCT06066528","title":"A Phase 3, Randomised, Double-blind, Parallel-group, 76-week, Efficacy and Safety Study of BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity and Type 2 Diabetes Mellitus","has_exemption":false,"start_date":"2023-11-27","completion_date":"2025-12-12","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06058793","publication_url":"https://clinicaltrials.gov/study/NCT06058793","title":"Brightline-4: A Phase III Open-label, Single-arm, Multi-center Study to Assess the Safety and Efficacy of Brigimadlin (BI 907828) Treatment in Patients With Treatment-naïve or Pre-treated Advanced Dedifferentiated Liposarcoma","has_exemption":false,"start_date":"2023-12-13","completion_date":"2025-12-12","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04056741","publication_url":"https://clinicaltrials.gov/study/NCT04056741","title":"A Supraglottic Instillation Device for Administration of Surfactant in Neonates- A Pilot Study","has_exemption":false,"start_date":"2025-02-07","completion_date":"2025-12-12","has_results":false,"results_due":false,"sponsor_name":"ONY","sponsor_slug":"ony","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06973720","publication_url":"https://clinicaltrials.gov/study/NCT06973720","title":"A Phase 2b, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of Multiple Dose Regimens of Once-Weekly Switching to Once-Monthly MET097 in Participants With Obesity or Overweight (VESPER-3)","has_exemption":false,"start_date":"2025-04-01","completion_date":"2025-12-12","has_results":false,"results_due":false,"sponsor_name":"Metsera, a wholly owned subsidiary of Pfizer","sponsor_slug":"metsera-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214740","publication_url":"https://clinicaltrials.gov/study/NCT07214740","title":"A Phase 3B, Single-Arm, Open-Label, Multicenter Study to Evaluate the Safety of Pegcetacoplan in a Prefilled Syringe in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration","has_exemption":false,"start_date":"2025-10-24","completion_date":"2025-12-12","has_results":false,"results_due":false,"sponsor_name":"Apellis Pharmaceuticals, Inc.","sponsor_slug":"apellis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03953768","publication_url":"https://clinicaltrials.gov/study/NCT03953768","title":"Prospective Non-randomized Single-arm Trial of Efferent Neuromodulation Immune and Gastrointestinal Systems by VNS in the Epilepsy Population","has_exemption":false,"start_date":"2021-04-01","completion_date":"2025-12-13","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02518555","publication_url":"https://clinicaltrials.gov/study/NCT02518555","title":"Early Intervention Trial of Ibrutinib for Patients With Asymptomatic, High-Risk Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","has_exemption":false,"start_date":"2016-01-12","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Jennifer Woyach","sponsor_slug":"jennifer-woyach","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03405155","publication_url":"https://clinicaltrials.gov/study/NCT03405155","title":"Phase II Study of Adjuvant Nivolumab in Patients With Resected Stage IIB/IIC Melanoma","has_exemption":false,"start_date":"2018-01-17","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04580043","publication_url":"https://clinicaltrials.gov/study/NCT04580043","title":"Experimental Manipulation of OFC Function and Behavioral Context: Towards an Integrative Translational Model of Compulsive Behaviors","has_exemption":false,"start_date":"2020-12-28","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Rebecca Price","sponsor_slug":"rebecca-price","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04653246","publication_url":"https://clinicaltrials.gov/study/NCT04653246","title":"Phase 2, Multi-Center, Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of the Combination Regimen Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2021-07-13","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Jacob Laubach, MD","sponsor_slug":"jacob-laubach-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04965090","publication_url":"https://clinicaltrials.gov/study/NCT04965090","title":"A Phase 2 Single-Arm Study of Amivantamab (JNJ-61186372) and Lazertinib in Metastatic EGFR-mutant Lung Cancer With Progressive or New CNS Metastases on Previous Treatment","has_exemption":false,"start_date":"2021-09-30","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05040321","publication_url":"https://clinicaltrials.gov/study/NCT05040321","title":"A Proof of Concept Trial of a Sirtuin-NAD Activator in Alzheimer's Disease","has_exemption":false,"start_date":"2021-12-01","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04778644","publication_url":"https://clinicaltrials.gov/study/NCT04778644","title":"Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task","has_exemption":false,"start_date":"2021-12-15","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Hartford Hospital","sponsor_slug":"hartford-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02397668","publication_url":"https://clinicaltrials.gov/study/NCT02397668","title":"CorMatrix Cor TRICUSPID ECM Valve Replacement Study","has_exemption":false,"start_date":"2022-08-01","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Corvivo Cardiovascular, Inc.","sponsor_slug":"corvivo-cardiovascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05767359","publication_url":"https://clinicaltrials.gov/study/NCT05767359","title":"CAR- PRISM (PRecision Intervention Smoldering Myeloma): A Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in High-Risk Smoldering Myeloma","has_exemption":false,"start_date":"2023-04-19","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07128316","publication_url":"https://clinicaltrials.gov/study/NCT07128316","title":"Comparison of Clinical Outcomes of LASIK Using Contoura With Phorcides vs. iDesign","has_exemption":false,"start_date":"2023-09-11","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"59th Medical Wing","sponsor_slug":"59th-medical-wing","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05640674","publication_url":"https://clinicaltrials.gov/study/NCT05640674","title":"A Randomized Controlled Trial of Opioid vs Non-Opioid Postoperative Pain Management in Children With Supracondylar Humerus Fractures","has_exemption":false,"start_date":"2023-09-12","completion_date":"2025-12-15","has_results":true,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06182319","publication_url":"https://clinicaltrials.gov/study/NCT06182319","title":"The Use of Nasogastric Tubes And Water-Soluble Contrast In The Management Of Small Bowel Obstruction: A Feasibility Study","has_exemption":false,"start_date":"2024-01-01","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06307613","publication_url":"https://clinicaltrials.gov/study/NCT06307613","title":"A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Thyroid Eye Disease","has_exemption":false,"start_date":"2024-03-27","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06307626","publication_url":"https://clinicaltrials.gov/study/NCT06307626","title":"A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Thyroid Eye Disease","has_exemption":false,"start_date":"2024-03-28","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06373146","publication_url":"https://clinicaltrials.gov/study/NCT06373146","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study of Once-Weekly Tirzepatide Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity","has_exemption":false,"start_date":"2024-04-24","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05889793","publication_url":"https://clinicaltrials.gov/study/NCT05889793","title":"Emetine for Viral Outbreaks: Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate Oral Emetine Against Covid-19 (EVOLVE)","has_exemption":false,"start_date":"2024-05-15","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06418984","publication_url":"https://clinicaltrials.gov/study/NCT06418984","title":"A Randomized Clinical Trial to Compare the Influence of Optimized Attachments, IPR and a Combination of Both Techniques on the Rotational Accuracy of Canines With Clear Aligners","has_exemption":false,"start_date":"2024-10-01","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06784986","publication_url":"https://clinicaltrials.gov/study/NCT06784986","title":"Impact of Using the Airseal System With Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: A Prospective, Comparative, Randomized Clinical Study.","has_exemption":false,"start_date":"2025-02-28","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Brazilian Institute of Robotic Surgery","sponsor_slug":"brazilian-institute-of-robotic-surgery","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06704009","publication_url":"https://clinicaltrials.gov/study/NCT06704009","title":"A Randomized, Open-Label, Parallel-group, Multicenter Phase 1/2 Study to Evaluate the Safety and Exploratory Efficacy of NT-101 Topical Ophthalmic Solution in Patients With Wet Age-Related Macular Degeneration (AMD)","has_exemption":false,"start_date":"2025-03-11","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"NexThera Co., Ltd.","sponsor_slug":"nexthera-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06966349","publication_url":"https://clinicaltrials.gov/study/NCT06966349","title":"Quantifying Ocular Surface Aberrations After Tear Film Interventions","has_exemption":false,"start_date":"2025-06-10","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"University of Waterloo","sponsor_slug":"university-of-waterloo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07086742","publication_url":"https://clinicaltrials.gov/study/NCT07086742","title":"Validation of the Smart Mask V1 System and Its Measurements of SpO2 and Pulse Rate","has_exemption":false,"start_date":"2025-09-01","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Pathway Medtech, LLC.","sponsor_slug":"pathway-medtech-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07138521","publication_url":"https://clinicaltrials.gov/study/NCT07138521","title":"Optimizing Linezolid Dosing in Patients With Advanced Renal Impairment: a Therapeutic Drug Monitoring-based Evaluation","has_exemption":false,"start_date":"2025-10-15","completion_date":"2025-12-15","has_results":false,"results_due":false,"sponsor_name":"Alexandria University","sponsor_slug":"alexandria-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02690545","publication_url":"https://clinicaltrials.gov/study/NCT02690545","title":"Phase Ib/II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Hodgkin's Lymphoma and CD30+ Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2016-08-26","completion_date":"2025-12-16","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04288323","publication_url":"https://clinicaltrials.gov/study/NCT04288323","title":"Abbreviated MRI (AMRI) vs. Ultrasound for HCC Surveillance in Cirrhosis","has_exemption":false,"start_date":"2018-04-27","completion_date":"2025-12-16","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04821310","publication_url":"https://clinicaltrials.gov/study/NCT04821310","title":"AN EXPLORATORY, MULTICENTER, RANDOMIZED, DOUBLE BLIND STUDY OF CLINICAL OUTCOMES, TOLERABILITY, AND SAFETY OF 2 DOSES OF ORAL PANTOPRAZOLE IN PEDIATRIC PARTICIPANTS AGED 1 TO 11 YEARS AND 12 TO 17 YEARS WHO REQUIRE MAINTENANCE THERAPY FOR HEALED EROSIVE ESOPHAGITIS","has_exemption":false,"start_date":"2022-01-13","completion_date":"2025-12-16","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05634785","publication_url":"https://clinicaltrials.gov/study/NCT05634785","title":"Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Patients With CD30+ Nonseminomatous Germ Cell Tumors (NSGCT)","has_exemption":false,"start_date":"2022-12-09","completion_date":"2025-12-16","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05695105","publication_url":"https://clinicaltrials.gov/study/NCT05695105","title":"Novel Treatment for Dental Ankylosis","has_exemption":false,"start_date":"2023-07-10","completion_date":"2025-12-16","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06196879","publication_url":"https://clinicaltrials.gov/study/NCT06196879","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center, Dose-ranging Study to Evaluate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)","has_exemption":false,"start_date":"2024-02-27","completion_date":"2025-12-16","has_results":false,"results_due":false,"sponsor_name":"Upstream Bio Inc.","sponsor_slug":"upstream-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06267001","publication_url":"https://clinicaltrials.gov/study/NCT06267001","title":"A Phase III, Randomized, Double-blind Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Stage IIB, IIIA, or Select IIIB, PD-L1 Positive, Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy","has_exemption":false,"start_date":"2024-03-21","completion_date":"2025-12-16","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07095712","publication_url":"https://clinicaltrials.gov/study/NCT07095712","title":"An Open-label Multicenter, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for Amyotrophic Lateral Sclerosis (ALS) Due to TARDBP (TDP-43) Genetic Mutation","has_exemption":false,"start_date":"2024-11-25","completion_date":"2025-12-16","has_results":false,"results_due":false,"sponsor_name":"n-Lorem Foundation","sponsor_slug":"n-lorem-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06910384","publication_url":"https://clinicaltrials.gov/study/NCT06910384","title":"An Open Label Study of STR04 in Participants With Amyotrophic Lateral Sclerosis","has_exemption":false,"start_date":"2025-08-12","completion_date":"2025-12-16","has_results":false,"results_due":false,"sponsor_name":"New England Cell Therapeutics, Inc.","sponsor_slug":"new-england-cell-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03728361","publication_url":"https://clinicaltrials.gov/study/NCT03728361","title":"A Phase II, Multi-Cohort Trial of Combination Nivolumab and Temozolomide in Recurrent/Refractory Small-Cell Lung Cancer and Advanced Neuroendocrine Tumors","has_exemption":false,"start_date":"2018-12-31","completion_date":"2025-12-17","has_results":false,"results_due":false,"sponsor_name":"Dwight Owen","sponsor_slug":"dwight-owen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04802174","publication_url":"https://clinicaltrials.gov/study/NCT04802174","title":"A Phase I/II Trial of Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High Grade Neuroendocrine Cancers","has_exemption":false,"start_date":"2021-06-01","completion_date":"2025-12-17","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05206773","publication_url":"https://clinicaltrials.gov/study/NCT05206773","title":"A Randomized, Double-blind, Placebo-controlled, 12-month Phase 3 Study to Evaluate the Effect of Venglustat on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease Who Are Treatment-naïve or Untreated for at Least 6 Months","has_exemption":false,"start_date":"2022-03-11","completion_date":"2025-12-17","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05629208","publication_url":"https://clinicaltrials.gov/study/NCT05629208","title":"A Randomized, Blinded, Placebo-Controlled, Phase 2a, Proof-of-Concept Study to Evaluate Efficacy, Safety, and Tolerability of GS-5718 in Participants With Cutaneous Lupus Erythematosus (CLE)","has_exemption":false,"start_date":"2023-04-17","completion_date":"2025-12-17","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06124014","publication_url":"https://clinicaltrials.gov/study/NCT06124014","title":"Cranial Electrotherapy Stimulation (CES) for the Treatment of Generalized Anxiety Disorder (GAD) in Young Adults: Double-Blind Sham-Controlled Randomized Clinical Trial","has_exemption":false,"start_date":"2024-01-26","completion_date":"2025-12-17","has_results":false,"results_due":false,"sponsor_name":"Electromedical Products International, Inc.","sponsor_slug":"electromedical-products-international-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05995899","publication_url":"https://clinicaltrials.gov/study/NCT05995899","title":"An Open-label, Single Center Investigator Sponsored Study Assessing the Effect of Tenapanor on Metagenomic and Metabolomic Markers in Patients With Irritable Bowel Syndrome With Constipation","has_exemption":false,"start_date":"2024-02-06","completion_date":"2025-12-17","has_results":false,"results_due":false,"sponsor_name":"Kyle Staller, MD, MPH","sponsor_slug":"kyle-staller-md-mph","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06193200","publication_url":"https://clinicaltrials.gov/study/NCT06193200","title":"A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Neurological Effects of EryDex on Subjects With Ataxia Telangiectasia (NEAT)","has_exemption":false,"start_date":"2024-06-24","completion_date":"2025-12-17","has_results":false,"results_due":false,"sponsor_name":"Quince Therapeutics S.p.A.","sponsor_slug":"quince-therapeutics-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06580912","publication_url":"https://clinicaltrials.gov/study/NCT06580912","title":"Krill Oil for Pain and Physical Function in Older Adults","has_exemption":false,"start_date":"2025-01-17","completion_date":"2025-12-17","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06821061","publication_url":"https://clinicaltrials.gov/study/NCT06821061","title":"A PHASE 1/2 RANDOMIZED, DOUBLE-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MODIFIED RNA VACCINE CANDIDATES AGAINST INFLUENZA AND COVID-19 IN HEALTHY INDIVIDUALS","has_exemption":false,"start_date":"2025-02-10","completion_date":"2025-12-17","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06785454","publication_url":"https://clinicaltrials.gov/study/NCT06785454","title":"A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Crossover Study to Evaluate the Efficacy and Safety of Lorundrostat in Participants With Moderate to Severe Obstructive Sleep Apnea and Hypertension","has_exemption":false,"start_date":"2025-02-28","completion_date":"2025-12-17","has_results":false,"results_due":false,"sponsor_name":"Mineralys Therapeutics Inc.","sponsor_slug":"mineralys-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06816875","publication_url":"https://clinicaltrials.gov/study/NCT06816875","title":"Comparative Analysis of Commercially Available Nasal Aspirators in Infants","has_exemption":false,"start_date":"2025-03-05","completion_date":"2025-12-17","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Eastern Ontario","sponsor_slug":"childrens-hospital-of-eastern-ontario","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07276347","publication_url":"https://clinicaltrials.gov/study/NCT07276347","title":"Comprehensive Assessment of Multiple Products (CAMP)","has_exemption":false,"start_date":"2025-11-12","completion_date":"2025-12-17","has_results":false,"results_due":false,"sponsor_name":"CooperVision International Limited (CVIL)","sponsor_slug":"coopervision-international-limited-cvil","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03712813","publication_url":"https://clinicaltrials.gov/study/NCT03712813","title":"Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors","has_exemption":false,"start_date":"2019-10-02","completion_date":"2025-12-18","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04138394","publication_url":"https://clinicaltrials.gov/study/NCT04138394","title":"VItamin C in Thermal injuRY: The VICToRY Trial A Phase III Multi-center Randomized Trial","has_exemption":false,"start_date":"2020-07-24","completion_date":"2025-12-18","has_results":false,"results_due":false,"sponsor_name":"Clinical Evaluation Research Unit at Kingston General Hospital","sponsor_slug":"clinical-evaluation-research-unit-at-kingston-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05093959","publication_url":"https://clinicaltrials.gov/study/NCT05093959","title":"Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction","has_exemption":false,"start_date":"2022-01-04","completion_date":"2025-12-18","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05543512","publication_url":"https://clinicaltrials.gov/study/NCT05543512","title":"An Allergen-specific Immune Signature-directed Diet vs Sham Diet for Treatment of Eosinophilic Esophagitis: A Pilot-feasibility Study","has_exemption":false,"start_date":"2022-10-14","completion_date":"2025-12-18","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05599191","publication_url":"https://clinicaltrials.gov/study/NCT05599191","title":"A Phase 3, 52-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study With Open-Label Extension of BLU-5937 in Adult Participants With Refractory Chronic Cough, Including Unexplained Chronic Cough (CALM-1)","has_exemption":false,"start_date":"2022-10-25","completion_date":"2025-12-18","has_results":false,"results_due":false,"sponsor_name":"Bellus Health Inc. - a GSK company","sponsor_slug":"bellus-health-inc-a-gsk-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06164951","publication_url":"https://clinicaltrials.gov/study/NCT06164951","title":"A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Infigratinib in Children 3 to <18 Years of Age With Achondroplasia: PROPEL 3","has_exemption":false,"start_date":"2023-11-10","completion_date":"2025-12-18","has_results":false,"results_due":false,"sponsor_name":"QED Therapeutics, a BridgeBio company","sponsor_slug":"qed-therapeutics-a-bridgebio-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05002998","publication_url":"https://clinicaltrials.gov/study/NCT05002998","title":"A Phase 3b/4, Double-masked, Randomized, International, Parallel-assignment, Multicenter Trial in Patients With Thyroid Eye Disease to Evaluate the Safety and Tolerability of Different Dosing Durations of Teprotumumab","has_exemption":false,"start_date":"2021-09-16","completion_date":"2025-12-19","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05937672","publication_url":"https://clinicaltrials.gov/study/NCT05937672","title":"Cold Atmospheric Plasma Device for the Treatment of Molluscum Contagiosum and Verruca Vulgaris in Pediatric Patients - Open-Label Extension Study","has_exemption":false,"start_date":"2023-09-18","completion_date":"2025-12-19","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06322342","publication_url":"https://clinicaltrials.gov/study/NCT06322342","title":"A Multi-Center, Phase 2, Open Label, Ascending Dose Study to Evaluate the Safety and Efficacy of RVP-001 and to Identify an Appropriate Dose to Detect CNS Lesions in Adult Patients","has_exemption":false,"start_date":"2024-08-15","completion_date":"2025-12-19","has_results":false,"results_due":false,"sponsor_name":"Reveal Pharmaceuticals Inc.","sponsor_slug":"reveal-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06492174","publication_url":"https://clinicaltrials.gov/study/NCT06492174","title":"AGENT IDE: A Prospective, Randomized (2:1), Multicenter Trial to Assess the Safety and Effectiveness of the AgentTM Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)","has_exemption":false,"start_date":"2024-10-07","completion_date":"2025-12-19","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06579105","publication_url":"https://clinicaltrials.gov/study/NCT06579105","title":"A Phase IIb, Randomized, Double-blind, Placebo-controlled and Open-label Active Comparator Study to Evaluate the Efficacy, Safety, and Tolerability of AZD5004 in Adults With Type 2 Diabetes Mellitus.","has_exemption":false,"start_date":"2024-10-08","completion_date":"2025-12-19","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05108558","publication_url":"https://clinicaltrials.gov/study/NCT05108558","title":"Efficacy of a Novel Collagenase Clostridium Histolyticum Protocol for Peyronie's Disease Among Prior Non-responders: A Randomized, Controlled, Single-Blinded Study","has_exemption":false,"start_date":"2021-09-20","completion_date":"2025-12-20","has_results":false,"results_due":false,"sponsor_name":"Charitable Union for the Research and Education of Peyronie's Disease","sponsor_slug":"charitable-union-for-the-research-and-education-of-peyronies-disease","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06817733","publication_url":"https://clinicaltrials.gov/study/NCT06817733","title":"Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging","has_exemption":false,"start_date":"2025-02-15","completion_date":"2025-12-20","has_results":false,"results_due":false,"sponsor_name":"Chinese PLA General Hospital","sponsor_slug":"chinese-pla-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06660758","publication_url":"https://clinicaltrials.gov/study/NCT06660758","title":"Pilot Study of the Entarik System With Advanced Functionality in Health Adults","has_exemption":false,"start_date":"2024-10-22","completion_date":"2025-12-21","has_results":false,"results_due":false,"sponsor_name":"Gravitas Medical, Inc.","sponsor_slug":"gravitas-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225478","publication_url":"https://clinicaltrials.gov/study/NCT07225478","title":"Clinical Study to Evaluate the Tooth Whitening Efficacy of a New NextGen In-office Whitening System","has_exemption":false,"start_date":"2025-10-31","completion_date":"2025-12-21","has_results":false,"results_due":false,"sponsor_name":"Colgate Palmolive","sponsor_slug":"colgate-palmolive","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01628029","publication_url":"https://clinicaltrials.gov/study/NCT01628029","title":"Multimodal Therapy for the Treatment of Sleep Disturbance in Patients With Cancer","has_exemption":false,"start_date":"2014-01-15","completion_date":"2025-12-22","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03384914","publication_url":"https://clinicaltrials.gov/study/NCT03384914","title":"A Multicenter Phase II Study of Vaccines to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer","has_exemption":false,"start_date":"2018-02-19","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03422822","publication_url":"https://clinicaltrials.gov/study/NCT03422822","title":"A PHASE 3 MULTI-CENTER, LONG-TERM EXTENSION STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ABROCITINIB, WITH OR WITHOUT TOPICAL MEDICATIONS, ADMINISTERED TO SUBJECTS AGED 12 YEARS AND OLDER WITH MODERATE TO SEVERE ATOPIC DERMATITIS","has_exemption":false,"start_date":"2018-03-08","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04193215","publication_url":"https://clinicaltrials.gov/study/NCT04193215","title":"A Study of V114 and Acute Otitis Media in Children (PNEU-ERA)","has_exemption":false,"start_date":"2020-09-12","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04629248","publication_url":"https://clinicaltrials.gov/study/NCT04629248","title":"A Phase III Randomized, Open-Label Active Comparator-Controlled Multicenter Study to Evaluate Efficacy and Safety of Obinutuzumab in Patients With Primary Membranous Nephropathy","has_exemption":false,"start_date":"2021-06-25","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05093634","publication_url":"https://clinicaltrials.gov/study/NCT05093634","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial: Multiple Independent Sub-studies of Setmelanotide in Patients With POMC/PCSK1, LEPR, NCOA1(SRC1), or SH2B1 Gene Variants in the Melanocortin-4 Receptor Pathway","has_exemption":false,"start_date":"2021-12-10","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"Rhythm Pharmaceuticals, Inc.","sponsor_slug":"rhythm-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05262530","publication_url":"https://clinicaltrials.gov/study/NCT05262530","title":"First-in-human, Open-label, Multicenter, Phase I/IIa, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of BNT142 in Patients With CLDN6-positive Advanced Solid Tumors","has_exemption":false,"start_date":"2022-03-22","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05450562","publication_url":"https://clinicaltrials.gov/study/NCT05450562","title":"A Phase 1/2 Open-label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR444200-based Regimen in Participants With Advanced Solid Tumors.","has_exemption":false,"start_date":"2022-09-20","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05704049","publication_url":"https://clinicaltrials.gov/study/NCT05704049","title":"A Randomized, Phase 2, Open Label Study Evaluating Subcutaneous Administration of Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)","has_exemption":false,"start_date":"2023-04-05","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05872854","publication_url":"https://clinicaltrials.gov/study/NCT05872854","title":"Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light","has_exemption":false,"start_date":"2023-08-21","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"Ellen Kim, MD","sponsor_slug":"ellen-kim-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05285683","publication_url":"https://clinicaltrials.gov/study/NCT05285683","title":"The Role of Dopamine in the Central Neural Signature of Chronic Pain","has_exemption":false,"start_date":"2024-01-31","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06464939","publication_url":"https://clinicaltrials.gov/study/NCT06464939","title":"A Randomized, Double-blinded, Placebo-controlled, Phase 2 Study to Assess the Efficacy and Safety of Three Topical Applications of KH001 in Providing Long-term Relief From Dentin Hypersensitivity","has_exemption":false,"start_date":"2024-10-08","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"HysensBio Co., Ltd","sponsor_slug":"hysensbio-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06155279","publication_url":"https://clinicaltrials.gov/study/NCT06155279","title":"Phase II Study of Pembrolizumab in Combination With Cisplatin or Carboplatin and Pemetrexed as Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)","has_exemption":false,"start_date":"2024-11-06","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"Istituto Oncologico Veneto IRCCS","sponsor_slug":"istituto-oncologico-veneto-irccs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06693648","publication_url":"https://clinicaltrials.gov/study/NCT06693648","title":"A Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Trial to Evaluate the Efficacy and Safety of Once Daily Diclofenac Gel AMZ001 in the Treatment of Pain and Symptoms of Knee Osteoarthritis","has_exemption":false,"start_date":"2025-02-18","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"Amzell","sponsor_slug":"amzell","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07029412","publication_url":"https://clinicaltrials.gov/study/NCT07029412","title":"A Phase 2a, Open-label, Exploratory Study to Evaluate Preliminary Efficacy of Subcutaneous MBX 1416 in Patients With Postbariatric Hypoglycemia (The STEADI Study)","has_exemption":false,"start_date":"2025-08-26","completion_date":"2025-12-22","has_results":false,"results_due":false,"sponsor_name":"MBX Biosciences","sponsor_slug":"mbx-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02131805","publication_url":"https://clinicaltrials.gov/study/NCT02131805","title":"A Multicenter Pilot Study of Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma","has_exemption":false,"start_date":"2014-05-31","completion_date":"2025-12-23","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04636814","publication_url":"https://clinicaltrials.gov/study/NCT04636814","title":"A 52-week, Randomized, Double-blind, Double-dummy, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg), Parallel Group, Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI add-on to Maintenance Triple Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis.","has_exemption":false,"start_date":"2021-07-12","completion_date":"2025-12-23","has_results":false,"results_due":false,"sponsor_name":"Chiesi Farmaceutici S.p.A.","sponsor_slug":"chiesi-farmaceutici-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05743946","publication_url":"https://clinicaltrials.gov/study/NCT05743946","title":"Evaluating Trikafta for the Treatment of Patients With Non-cystic Fibrosis Bronchiectasis (NCFBE)","has_exemption":false,"start_date":"2023-04-18","completion_date":"2025-12-23","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06043830","publication_url":"https://clinicaltrials.gov/study/NCT06043830","title":"Managing Opioid Related Sleep Apnea With Acetazolamide","has_exemption":false,"start_date":"2023-10-18","completion_date":"2025-12-23","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05987670","publication_url":"https://clinicaltrials.gov/study/NCT05987670","title":"Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope","has_exemption":false,"start_date":"2023-10-25","completion_date":"2025-12-23","has_results":false,"results_due":false,"sponsor_name":"Imperial College London","sponsor_slug":"imperial-college-london","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06661473","publication_url":"https://clinicaltrials.gov/study/NCT06661473","title":"An Interventional Study to Explore the Occurrence of Surgical Site Complications in High-risk Patients After Revision of Total Hip or Knee Joint Arthroplasty Receiving Closed Incision Negative Pressure Wound Therapy.","has_exemption":false,"start_date":"2024-10-03","completion_date":"2025-12-23","has_results":false,"results_due":false,"sponsor_name":"Molnlycke Health Care AB","sponsor_slug":"molnlycke-health-care-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05417789","publication_url":"https://clinicaltrials.gov/study/NCT05417789","title":"A Phase III, Multicentre, Randomised, Double-Blind Study to Assess the Safety and Efficacy of Emactuzumab vs. Placebo in Subjects With Tenosynovial Giant Cell Tumour","has_exemption":false,"start_date":"2024-10-09","completion_date":"2025-12-23","has_results":false,"results_due":false,"sponsor_name":"SynOx Therapeutics Limited","sponsor_slug":"synox-therapeutics-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06038539","publication_url":"https://clinicaltrials.gov/study/NCT06038539","title":"A Multicenter, Double-blind, Randomized, Parallel-group, Phase 3 Study to Compare the Efficacy and Safety of the Proposed Biosimilar PERT-IJS and EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Patients With Hormone Receptor Negative (HR-ve) Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Stage or Locally Advanced Breast Cancer","has_exemption":false,"start_date":"2025-01-06","completion_date":"2025-12-23","has_results":false,"results_due":false,"sponsor_name":"Biocon Biologics UK Ltd","sponsor_slug":"biocon-biologics-uk-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02917993","publication_url":"https://clinicaltrials.gov/study/NCT02917993","title":"An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2016-12-20","completion_date":"2025-12-24","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05316311","publication_url":"https://clinicaltrials.gov/study/NCT05316311","title":"Implantation of CERENOVUS ENTERPRISE 2 Intracranial Stent in Patients With Severe Symptomatic Intracranial Atherosclerotic Stenosis: A Multicenter, Prospective and Single-Arm Study in China","has_exemption":false,"start_date":"2022-05-24","completion_date":"2025-12-24","has_results":false,"results_due":false,"sponsor_name":"Medos International SARL","sponsor_slug":"medos-international-sarl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05375994","publication_url":"https://clinicaltrials.gov/study/NCT05375994","title":"A Phase 1/2 Study of Avutometinib (VS-6766) in Combination With Adagrasib in Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer (NSCLC) (RAMP 204)","has_exemption":false,"start_date":"2022-08-01","completion_date":"2025-12-24","has_results":false,"results_due":false,"sponsor_name":"Verastem, Inc.","sponsor_slug":"verastem-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06173505","publication_url":"https://clinicaltrials.gov/study/NCT06173505","title":"A Phase 1b/2, Open-label, Randomized Study of Vudalimab in Combination With Chemotherapy or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2023-12-27","completion_date":"2025-12-24","has_results":false,"results_due":false,"sponsor_name":"Xencor, Inc.","sponsor_slug":"xencor-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07039461","publication_url":"https://clinicaltrials.gov/study/NCT07039461","title":"Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion","has_exemption":false,"start_date":"2025-09-12","completion_date":"2025-12-24","has_results":false,"results_due":false,"sponsor_name":"Lumenis Be Ltd.","sponsor_slug":"lumenis-be-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05477524","publication_url":"https://clinicaltrials.gov/study/NCT05477524","title":"A Phase 3, Multicenter, Placebo-Controlled, Randomized, Observer-Blinded Trial to Evaluate the Efficacy, Safety, Tolerability, Immunogenicity, and Lot Consistency of a 6-Valent OspA-Based Lyme Disease Vaccine in Healthy Participants ≥5 Years of Age","has_exemption":false,"start_date":"2022-08-04","completion_date":"2025-12-26","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05661578","publication_url":"https://clinicaltrials.gov/study/NCT05661578","title":"A Phase II, Single-Arm, Open-Label Study Evaluating the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors","has_exemption":false,"start_date":"2023-05-04","completion_date":"2025-12-26","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06802536","publication_url":"https://clinicaltrials.gov/study/NCT06802536","title":"Treatment Outcomes of Full Pulpotomy Using Two Different Calcium Silicate-based Materials in Mature Permanent Teeth With Irreversible Pulpitis Symptoms: A Randomized Clinical Trial","has_exemption":false,"start_date":"2024-04-15","completion_date":"2025-12-26","has_results":false,"results_due":false,"sponsor_name":"Firat University","sponsor_slug":"firat-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04302324","publication_url":"https://clinicaltrials.gov/study/NCT04302324","title":"A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab","has_exemption":false,"start_date":"2021-10-28","completion_date":"2025-12-28","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02763033","publication_url":"https://clinicaltrials.gov/study/NCT02763033","title":"Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients","has_exemption":false,"start_date":"2017-04-26","completion_date":"2025-12-29","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04831684","publication_url":"https://clinicaltrials.gov/study/NCT04831684","title":"Effects of a Novel mGluR5 Negative Allosteric Modulator on Alcohol Drinking, Neurochemistry, and Brain Reactivity to Alcohol Cues in Alcohol Use Disorder","has_exemption":false,"start_date":"2021-09-15","completion_date":"2025-12-29","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05238116","publication_url":"https://clinicaltrials.gov/study/NCT05238116","title":"A Double-blind, Randomized, Placebo-controlled Study to Assess the Safety and Efficacy of Nebulized PC945 When Added to Systemic Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study)","has_exemption":false,"start_date":"2022-06-14","completion_date":"2025-12-29","has_results":false,"results_due":false,"sponsor_name":"Pulmocide Ltd","sponsor_slug":"pulmocide-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05650645","publication_url":"https://clinicaltrials.gov/study/NCT05650645","title":"The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial","has_exemption":false,"start_date":"2023-01-01","completion_date":"2025-12-29","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05877547","publication_url":"https://clinicaltrials.gov/study/NCT05877547","title":"A Phase 2b Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Adults With Precirrhotic Nonalcoholic Steatohepatitis","has_exemption":false,"start_date":"2023-06-23","completion_date":"2025-12-29","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06212557","publication_url":"https://clinicaltrials.gov/study/NCT06212557","title":"Evaluation of KIOS in a 12-week Randomized Controlled Trial","has_exemption":false,"start_date":"2024-05-02","completion_date":"2025-12-29","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06422507","publication_url":"https://clinicaltrials.gov/study/NCT06422507","title":"Multi-Center, Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of 8 mg Aflibercept in Chinese Participants With Diabetic Macular Edema","has_exemption":false,"start_date":"2024-05-29","completion_date":"2025-12-29","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06716203","publication_url":"https://clinicaltrials.gov/study/NCT06716203","title":"A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of BGM0504 Versus Placebo in Patients with Type 2 Diabetes, Inadequately Controlled with Diet and Exercise Alone","has_exemption":false,"start_date":"2024-12-02","completion_date":"2025-12-29","has_results":false,"results_due":false,"sponsor_name":"BrightGene Bio-Medical Technology Co., Ltd.","sponsor_slug":"brightgene-bio-medical-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07040059","publication_url":"https://clinicaltrials.gov/study/NCT07040059","title":"A Phase 1b/2, Open-label, Randomized, Multicenter Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma (BHARAT-2)","has_exemption":false,"start_date":"2025-03-22","completion_date":"2025-12-29","has_results":false,"results_due":false,"sponsor_name":"Aurigene Discovery Technologies Limited","sponsor_slug":"aurigene-discovery-technologies-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00716066","publication_url":"https://clinicaltrials.gov/study/NCT00716066","title":"High-Dose Immunosuppressive Therapy Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) + Thymoglobulin Followed by Syngeneic or Autologous Hematopoietic Cell Transplantation for Patients With Autoimmune Neurologic Diseases","has_exemption":false,"start_date":"2008-06-30","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02767804","publication_url":"https://clinicaltrials.gov/study/NCT02767804","title":"Phase 3 Randomized Study Comparing X-396 (Ensartinib) to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients","has_exemption":false,"start_date":"2016-06-30","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Xcovery Holdings, Inc.","sponsor_slug":"xcovery-holdings-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03115983","publication_url":"https://clinicaltrials.gov/study/NCT03115983","title":"A Concurrently Controlled Study of the LimiFlex™ Paraspinous Tension Band in the Treatment of Lumbar Degenerative Spondylolisthesis With Spinal Stenosis","has_exemption":false,"start_date":"2017-07-17","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Empirical Spine, Inc.","sponsor_slug":"empirical-spine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03456089","publication_url":"https://clinicaltrials.gov/study/NCT03456089","title":"Measurement of Bladder Pressure With a Novel External Device, Comparison to Urodynamics Testing","has_exemption":false,"start_date":"2018-04-15","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Christopher Cooper","sponsor_slug":"christopher-cooper","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02956798","publication_url":"https://clinicaltrials.gov/study/NCT02956798","title":"Phase II Trial of SAbR for Patients With Oligometastatic Renal Cell Carcinoma","has_exemption":false,"start_date":"2018-07-19","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03611868","publication_url":"https://clinicaltrials.gov/study/NCT03611868","title":"A Phase Ib/II Study of APG-115 as a Monotherapy or in Combination With Pembrolizumab in Patients With Unresectable or Metastatic Melanomas or Advanced Solid Tumors","has_exemption":false,"start_date":"2018-08-29","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Ascentage Pharma Group Inc.","sponsor_slug":"ascentage-pharma-group-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03642964","publication_url":"https://clinicaltrials.gov/study/NCT03642964","title":"A Phase 2a Study to Evaluate the Safety, Tolerability and Initial Efficacy of Pramipexole IR, Given With Ondansetron in Patients With Major Depressive Disorder","has_exemption":false,"start_date":"2018-09-10","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Chase Therapeutics Corporation","sponsor_slug":"chase-therapeutics-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03630055","publication_url":"https://clinicaltrials.gov/study/NCT03630055","title":"Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion","has_exemption":false,"start_date":"2018-10-03","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Ottawa Heart Institute Research Corporation","sponsor_slug":"ottawa-heart-institute-research-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03562637","publication_url":"https://clinicaltrials.gov/study/NCT03562637","title":"The GLORIA Study: A Phase 3, Randomized, Open-Label Study of the Anti-Globo H Vaccine Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With High Risk, Early Stage Globo H-Positive Triple Negative Breast Cancer","has_exemption":false,"start_date":"2018-12-05","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"OBI Pharma, Inc","sponsor_slug":"obi-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03683225","publication_url":"https://clinicaltrials.gov/study/NCT03683225","title":"A Phase 2 Study to Evaluate the Safety, Tolerability and Initial Efficacy of Pramipexole ER, Given With Aprepitant in Patients With Idiopathic Parkinson's Disease","has_exemption":false,"start_date":"2019-04-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Chase Therapeutics Corporation","sponsor_slug":"chase-therapeutics-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03717623","publication_url":"https://clinicaltrials.gov/study/NCT03717623","title":"Pharmacokinetics Study of Posaconazole in Haematology Patients Receiving Standard of Care Treatment With Oral Posaconazole Prophylaxis for Invasive Fungal Infection","has_exemption":false,"start_date":"2019-08-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Melbourne Health","sponsor_slug":"melbourne-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04083599","publication_url":"https://clinicaltrials.gov/study/NCT04083599","title":"A First-in-Human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety and Anti-tumor Activity of GEN1042 in Subjects With Malignant Solid Tumors","has_exemption":false,"start_date":"2019-09-17","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04294810","publication_url":"https://clinicaltrials.gov/study/NCT04294810","title":"A Phase III, Randomized, Double-Blinded, Placebo-Controlled Study of Tiragolumab, an Anti-Tigit Antibody, in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2020-03-04","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04233749","publication_url":"https://clinicaltrials.gov/study/NCT04233749","title":"The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans","has_exemption":false,"start_date":"2020-03-17","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04214067","publication_url":"https://clinicaltrials.gov/study/NCT04214067","title":"A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer","has_exemption":false,"start_date":"2020-04-09","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04438213","publication_url":"https://clinicaltrials.gov/study/NCT04438213","title":"Ertugliflozin in Chronic Heart Failure: Cardio-renal and Diuretic Effects","has_exemption":false,"start_date":"2021-03-10","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04766255","publication_url":"https://clinicaltrials.gov/study/NCT04766255","title":"Behavioral Comparison of Three Different Graft Materials to Increase Soft Tissue Thickness Around Dental Implants in Terms of Volume Gain and Stability Over Time: A Randomized Clinical Trial.","has_exemption":false,"start_date":"2021-05-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Universitat Internacional de Catalunya","sponsor_slug":"universitat-internacional-de-catalunya","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05853718","publication_url":"https://clinicaltrials.gov/study/NCT05853718","title":"Study to Evaluate the Pharmacokinetic, Safety, and Efficacy of TAF in HBV-Infected Pregnant Women","has_exemption":false,"start_date":"2021-05-06","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"First People's Hospital of Hangzhou","sponsor_slug":"first-peoples-hospital-of-hangzhou","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05183152","publication_url":"https://clinicaltrials.gov/study/NCT05183152","title":"Non-invasive Brain-computer Interfaces for Control of Assistive Devices","has_exemption":false,"start_date":"2021-06-16","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05231798","publication_url":"https://clinicaltrials.gov/study/NCT05231798","title":"Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition","has_exemption":false,"start_date":"2021-08-19","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05030272","publication_url":"https://clinicaltrials.gov/study/NCT05030272","title":"Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings","has_exemption":false,"start_date":"2021-09-21","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03885245","publication_url":"https://clinicaltrials.gov/study/NCT03885245","title":"Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes to Increase Airway L-arginine/ADMA Ratio and Improve Asthma Control","has_exemption":false,"start_date":"2021-10-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04851301","publication_url":"https://clinicaltrials.gov/study/NCT04851301","title":"Neural Mechanisms of Immersive Virtual Reality in Chronic Pain","has_exemption":false,"start_date":"2021-11-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06096090","publication_url":"https://clinicaltrials.gov/study/NCT06096090","title":"A Phase II Clinical Trial of Interleukin-2 (IL-2) in Patients With Mild to Moderate Alzheimer's Disease","has_exemption":false,"start_date":"2022-01-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04941937","publication_url":"https://clinicaltrials.gov/study/NCT04941937","title":"Selinexor in Combination With Immunomodulator to Treat Relapsed/Refractory Multiple Myeloma Patients","has_exemption":false,"start_date":"2022-01-27","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Juan Du","sponsor_slug":"juan-du","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05383274","publication_url":"https://clinicaltrials.gov/study/NCT05383274","title":"Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters","has_exemption":false,"start_date":"2022-02-14","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Urotronic Inc.","sponsor_slug":"urotronic-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04907071","publication_url":"https://clinicaltrials.gov/study/NCT04907071","title":"Intravascular Ultrasound for the Evaluation of Malperfusion Syndrome in the Setting of Acute Aortic Dissection: A Pilot Study.","has_exemption":false,"start_date":"2022-03-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"London Health Sciences Centre","sponsor_slug":"london-health-sciences-centre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05275478","publication_url":"https://clinicaltrials.gov/study/NCT05275478","title":"A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG908 in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2022-03-23","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Tango Therapeutics, Inc.","sponsor_slug":"tango-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05521438","publication_url":"https://clinicaltrials.gov/study/NCT05521438","title":"A Multicenter, Randomized, Vehicle-Controlled, Double-Blind, Parallel Comparison Study of QRX003 Lotion in Subjects With Netherton Syndrome","has_exemption":false,"start_date":"2022-06-23","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Quoin Pharmaceuticals","sponsor_slug":"quoin-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05627700","publication_url":"https://clinicaltrials.gov/study/NCT05627700","title":"A Prospective, Open-label, Single-center Study of the Atia™ AVL200 Modular Intraocular Lens System for Treatment of Cataract and Presbyopia","has_exemption":false,"start_date":"2022-07-25","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Atia Vision","sponsor_slug":"atia-vision","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05394103","publication_url":"https://clinicaltrials.gov/study/NCT05394103","title":"A Phase 1/2 Multicenter, Open-label, Dose-escalation, Safety, Pharmacodynamic, and Pharmacokinetic Study of Q901Administered Via Intravenous Infusion as Monotherapy and in Combination With Pembrolizumab in Adult Patients With Selected Advanced Solid Tumors With Cohort Expansions at the Recommended Phase 2 Dose","has_exemption":false,"start_date":"2022-08-30","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Qurient Co., Ltd.","sponsor_slug":"qurient-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05573308","publication_url":"https://clinicaltrials.gov/study/NCT05573308","title":"Optimizing Clear Aligners Efficiency With Remote Dental Monitoring and Artificial Intelligence Algorithms","has_exemption":false,"start_date":"2022-10-17","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05674539","publication_url":"https://clinicaltrials.gov/study/NCT05674539","title":"Reduced Intensity Conditioning With Fludarabine and Busulfan Versus Fludarabine and Melphalan Before Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Randomised, Multi-Center, Phase III Study","has_exemption":false,"start_date":"2023-02-15","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","sponsor_slug":"union-hospital-tongji-medical-college-huazhong-university-of-science-and-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05789056","publication_url":"https://clinicaltrials.gov/study/NCT05789056","title":"A Multicenter, Open Label Study of QRX003 Lotion in Subjects With Netherton Syndrome","has_exemption":false,"start_date":"2023-03-14","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Quoin Pharmaceuticals","sponsor_slug":"quoin-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06384378","publication_url":"https://clinicaltrials.gov/study/NCT06384378","title":"Central and Peripheral Immune Cross-talk in Alzheimer's Disease and Their Modulation by a Novel Immunotherapy","has_exemption":false,"start_date":"2023-03-17","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05295615","publication_url":"https://clinicaltrials.gov/study/NCT05295615","title":"Effects of PEMF Treatment on Patients With Mild to Moderate Alzheimer's Disease in a Controlled Pilot Study","has_exemption":false,"start_date":"2023-05-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Herrick Medical LLC","sponsor_slug":"herrick-medical-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05930210","publication_url":"https://clinicaltrials.gov/study/NCT05930210","title":"A Randomized, Double-Blind, Vehicle-controlled, Parallel, Phase III Study to Evaluate Efficacy and Safety of ENERGI-F703 GEL in Subjects With Diabetic Foot Ulcers","has_exemption":false,"start_date":"2023-05-30","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Energenesis Biomedical Co., Ltd.","sponsor_slug":"energenesis-biomedical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05968430","publication_url":"https://clinicaltrials.gov/study/NCT05968430","title":"An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension","has_exemption":false,"start_date":"2023-07-14","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Mineralys Therapeutics Inc.","sponsor_slug":"mineralys-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05847348","publication_url":"https://clinicaltrials.gov/study/NCT05847348","title":"A Prospective, Open-Label, Single-Arm, Multi-center Study to Evaluate the Diagnostic Efficacy and Safety of 68Ga-PSMA-11 PET/CT or PET/MRI in Patients With Biochemical Recurrent Prostate Cancer","has_exemption":false,"start_date":"2023-07-19","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Telix Pharmaceuticals (Innovations) Pty Limited","sponsor_slug":"telix-pharmaceuticals-innovations-pty-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003309","publication_url":"https://clinicaltrials.gov/study/NCT06003309","title":"Frequency and E-field Enhancement of ITBS for Depression (FREED)","has_exemption":false,"start_date":"2023-08-31","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06041048","publication_url":"https://clinicaltrials.gov/study/NCT06041048","title":"Investigation of Locus Coeruleus Function in Sustained Attention","has_exemption":false,"start_date":"2023-10-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06119685","publication_url":"https://clinicaltrials.gov/study/NCT06119685","title":"Phase 1/2 Study of IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers","has_exemption":false,"start_date":"2023-10-25","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Indapta Therapeutics, INC.","sponsor_slug":"indapta-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06366698","publication_url":"https://clinicaltrials.gov/study/NCT06366698","title":"Randomized Control Trial: Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia in Pregnancy","has_exemption":false,"start_date":"2023-11-21","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Arrowhead Regional Medical Center","sponsor_slug":"arrowhead-regional-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06074380","publication_url":"https://clinicaltrials.gov/study/NCT06074380","title":"Non Inferiority Trial Investigating Surfactants Administered Via MIST","has_exemption":false,"start_date":"2024-01-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Endeavor Health","sponsor_slug":"endeavor-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05374915","publication_url":"https://clinicaltrials.gov/study/NCT05374915","title":"An Open-Labeled, Single Arm Phase 2 Efficacy and Safety Study of REM-001 Photodynamic Therapy (PDT) for Treatment of Cutaneous Metastatic Breast Cancer (CMBC) That is Refractory or Not Eligible for Radiotherapy or Surgery","has_exemption":false,"start_date":"2024-02-12","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Kintara Therapeutics, Inc.","sponsor_slug":"kintara-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06238245","publication_url":"https://clinicaltrials.gov/study/NCT06238245","title":"A Prospective, Single-Arm Clinical Study of Anti-thymocyte Globulin-based Conditioning Regimen Combined With Post-Transplantation Cyclophosphamide for GVHD Prevention in Allogeneic HSCT After PD-1 Blockade","has_exemption":false,"start_date":"2024-02-28","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Beijing 302 Hospital","sponsor_slug":"beijing-302-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07063524","publication_url":"https://clinicaltrials.gov/study/NCT07063524","title":"Principle Investigator","has_exemption":false,"start_date":"2024-05-10","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Western Michigan University","sponsor_slug":"western-michigan-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06296082","publication_url":"https://clinicaltrials.gov/study/NCT06296082","title":"Comparative Study of the Mechanism of Action of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity: a Proof of Concept Controlled Trial","has_exemption":false,"start_date":"2024-09-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Universiteit Antwerpen","sponsor_slug":"universiteit-antwerpen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06559969","publication_url":"https://clinicaltrials.gov/study/NCT06559969","title":"Randomized Controlled Study Comparing the Administration of Opioids Epidurally vs IV in Patients Undergoing Laparotomy With an Epidural for Post-Operative Analgesia","has_exemption":false,"start_date":"2024-09-17","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06746636","publication_url":"https://clinicaltrials.gov/study/NCT06746636","title":"Comparison Between Four Weaning Methods from High-velocity Nasal Insufflation Device in Acute Hypoxemic Respiratory Failure","has_exemption":false,"start_date":"2025-01-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06683417","publication_url":"https://clinicaltrials.gov/study/NCT06683417","title":"Vestibular Rehabilitation Aid (VestAid)","has_exemption":false,"start_date":"2025-01-15","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"BlueHalo","sponsor_slug":"bluehalo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06577779","publication_url":"https://clinicaltrials.gov/study/NCT06577779","title":"An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening","has_exemption":false,"start_date":"2025-01-29","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06995144","publication_url":"https://clinicaltrials.gov/study/NCT06995144","title":"A Randomized, Two-Period, Two-Arm, Double-Dummy, Crossover Study to Compare Natriuretic Effects of Extended Release Torsemide to Immediate Release Torsemide in Patients With Heart Failure (NEXT-HF)","has_exemption":false,"start_date":"2025-05-28","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Sarfez Pharmaceuticals, Inc.","sponsor_slug":"sarfez-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07043634","publication_url":"https://clinicaltrials.gov/study/NCT07043634","title":"An Open Label, Randomized, Two-period, Two-sequence, Balanced, Single Dose Crossover Study to Evaluate the Effect of Food on the Bioavailability of Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Human Subjects","has_exemption":false,"start_date":"2025-06-15","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Sarfez Pharmaceuticals, Inc.","sponsor_slug":"sarfez-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07015671","publication_url":"https://clinicaltrials.gov/study/NCT07015671","title":"Bioavailability and Bioequivalence (BA/BE) Study of Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Subjects","has_exemption":false,"start_date":"2025-07-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Sarfez Pharmaceuticals, Inc.","sponsor_slug":"sarfez-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07091331","publication_url":"https://clinicaltrials.gov/study/NCT07091331","title":"Clinical Evaluation of 3D-printed Ceromer Crowns Versus Stainless Steel in Posterior Primary Molars","has_exemption":false,"start_date":"2025-07-30","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Universidad Autonoma de Baja California","sponsor_slug":"universidad-autonoma-de-baja-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07155070","publication_url":"https://clinicaltrials.gov/study/NCT07155070","title":"Kera Sol Post-LASIK: A Benefit Study","has_exemption":false,"start_date":"2025-08-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Vance Thompson Vision","sponsor_slug":"vance-thompson-vision","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06851481","publication_url":"https://clinicaltrials.gov/study/NCT06851481","title":"A Prospective, Multi-Center, Single-Arm Study to Evaluate the Safety and Performance of the Ladera Medical Suture-Mediated Closure System When Used to Achieve Hemostasis of Common Femoral Arteriotomies in Patients Undergoing Percutaneous Catheter-Based Interventional Procedures (the FASTEN Study)","has_exemption":false,"start_date":"2025-08-18","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Ladera Medical","sponsor_slug":"ladera-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07210138","publication_url":"https://clinicaltrials.gov/study/NCT07210138","title":"The Clinical Investigation of PerioGard (Test) Regimen Compared to Control Regimen in Reducing Plaque and Gingivitis - a Three-month Study in Thailand","has_exemption":false,"start_date":"2025-08-18","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Colgate Palmolive","sponsor_slug":"colgate-palmolive","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07195669","publication_url":"https://clinicaltrials.gov/study/NCT07195669","title":"Nonopioid Versus Opioid Management of Post-operative Pain Following Oral & Maxillofacial Surgery: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-10-01","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Jacob Lensing","sponsor_slug":"jacob-lensing","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011888","publication_url":"https://clinicaltrials.gov/study/NCT07011888","title":"Current and Innovative Physiotherapy Practices in Stroke Rehabilitation: A Clinical Case Report","has_exemption":false,"start_date":"2025-11-15","completion_date":"2025-12-30","has_results":false,"results_due":false,"sponsor_name":"Sevval Yesilkır","sponsor_slug":"sevval-yesilkr","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00082706","publication_url":"https://clinicaltrials.gov/study/NCT00082706","title":"Phase II Trial of 5-FU, Leucovorin, Gemcitabine, and Cisplatin for Adenocarcinomas of the Urothelial Tract and Urachal Remnant","has_exemption":false,"start_date":"2003-04-23","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00248287","publication_url":"https://clinicaltrials.gov/study/NCT00248287","title":"Randomized Phase II Study of Weekly Irinotecan/Carboplatin (ICb) With or Without Cetuximab (Erbitux) in Patients With Metastatic Breast Cancer","has_exemption":false,"start_date":"2005-07-28","completion_date":"2025-12-31","has_results":true,"results_due":false,"sponsor_name":"US Oncology Research","sponsor_slug":"us-oncology-research","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT04842071","publication_url":"https://clinicaltrials.gov/study/NCT04842071","title":"Open-label Clinical Trial on the Safety and Efficacy of 18F-sodium Fluoride (NaF) PET Imaging in Patients in Need of a Standard 99mTc Bone Scintigraphy","has_exemption":false,"start_date":"2008-01-01","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Centre de recherche du Centre hospitalier universitaire de Sherbrooke","sponsor_slug":"centre-de-recherche-du-centre-hospitalier-universitaire-de-sherbrooke","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01050855","publication_url":"https://clinicaltrials.gov/study/NCT01050855","title":"Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders","has_exemption":false,"start_date":"2008-01-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01773278","publication_url":"https://clinicaltrials.gov/study/NCT01773278","title":"Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)","has_exemption":false,"start_date":"2008-12-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03437395","publication_url":"https://clinicaltrials.gov/study/NCT03437395","title":"Accelerated Partial Breast Irradiation Study for Women With Stage 0 or 1 Breast Cancer","has_exemption":false,"start_date":"2009-03-11","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Sentara Norfolk General Hospital","sponsor_slug":"sentara-norfolk-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01372566","publication_url":"https://clinicaltrials.gov/study/NCT01372566","title":"Effect of Autologous Platelet-rich Plasma on Photoaged Skin: A Prospective Randomized Controlled Trial (Phases A and B)","has_exemption":false,"start_date":"2011-05-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01547442","publication_url":"https://clinicaltrials.gov/study/NCT01547442","title":"Artisan Aphakia Lens for the Correction of Aphakia in Children","has_exemption":false,"start_date":"2012-01-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Ophtec USA","sponsor_slug":"ophtec-usa","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01461837","publication_url":"https://clinicaltrials.gov/study/NCT01461837","title":"Familial Haploidentical T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease (IND 14359)","has_exemption":false,"start_date":"2012-01-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01547429","publication_url":"https://clinicaltrials.gov/study/NCT01547429","title":"Artisan Aphakia Lens for the Correction of Aphakia in Adults","has_exemption":false,"start_date":"2012-01-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Ophtec USA","sponsor_slug":"ophtec-usa","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01617161","publication_url":"https://clinicaltrials.gov/study/NCT01617161","title":"Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs IMRT for Low or Intermediate Risk Prostate Cancer","has_exemption":false,"start_date":"2012-07-25","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01891318","publication_url":"https://clinicaltrials.gov/study/NCT01891318","title":"Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study","has_exemption":false,"start_date":"2013-07-03","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01871454","publication_url":"https://clinicaltrials.gov/study/NCT01871454","title":"Effect of Pentoxifylline and Vitamin E in Preventing Radiation-induced Toxicity in the Treatment of Recurrent or New Primary NSCLC Using Stereotactic Ablative Radiotherapy in Patients Previously Treated With Thoracic Radiation","has_exemption":false,"start_date":"2013-10-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01976260","publication_url":"https://clinicaltrials.gov/study/NCT01976260","title":"A Pilot, Split-Face Randomized, Evaluator Blinded Study on the Effectiveness of a Bipolar Fractional Radiofrequency System Versus 1550-nm Fractional Photothermolysis for the Treatment of Acne Scars.","has_exemption":false,"start_date":"2013-10-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01860612","publication_url":"https://clinicaltrials.gov/study/NCT01860612","title":"Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects","has_exemption":false,"start_date":"2013-10-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Clinical Research Consultants, Inc.","sponsor_slug":"clinical-research-consultants-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01957722","publication_url":"https://clinicaltrials.gov/study/NCT01957722","title":"A Phase 3, Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D Compared ot Microfracture in the Treatment of Articular Cartilage Defects","has_exemption":false,"start_date":"2013-12-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Aesculap Biologics, LLC","sponsor_slug":"aesculap-biologics-llc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01933724","publication_url":"https://clinicaltrials.gov/study/NCT01933724","title":"The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach","has_exemption":false,"start_date":"2014-02-17","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of South Florida","sponsor_slug":"university-of-south-florida","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02128152","publication_url":"https://clinicaltrials.gov/study/NCT02128152","title":"Effect of Mobility Training Using Robotic Exoskeletons on Functional Recovery in Individuals With Severe Stroke","has_exemption":false,"start_date":"2014-02-28","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Shirley Ryan AbilityLab","sponsor_slug":"shirley-ryan-abilitylab","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02089880","publication_url":"https://clinicaltrials.gov/study/NCT02089880","title":"Micro-processor Controlled Knee-Ankle-Foot Orthosis (C-Brace) Versus Stance-control Knee-Ankle-Foot Orthosis (SCO): Functional Outcomes in Individuals With Lower Extremity Impairment","has_exemption":false,"start_date":"2014-02-28","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Shirley Ryan AbilityLab","sponsor_slug":"shirley-ryan-abilitylab","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02378428","publication_url":"https://clinicaltrials.gov/study/NCT02378428","title":"A Phase II Study of <131>I-Metaiodobenzyguanidine (<131>I-MIBG) Therapy for Patients With MIBG Avid Tumors","has_exemption":false,"start_date":"2014-03-01","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02041936","publication_url":"https://clinicaltrials.gov/study/NCT02041936","title":"Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study","has_exemption":false,"start_date":"2014-04-30","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02216838","publication_url":"https://clinicaltrials.gov/study/NCT02216838","title":"Treatment of Facial Flushing With Botulinum Toxin A Injections: A Split-Face, Double-blinded, Randomized Control Trial","has_exemption":false,"start_date":"2014-08-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02318654","publication_url":"https://clinicaltrials.gov/study/NCT02318654","title":"Comparing the Efficacy of Ice Pack Versus Topical EMLA for Pain Control in Laser Axillary Hair Removal: A Randomized Control Trial","has_exemption":false,"start_date":"2014-12-30","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02993198","publication_url":"https://clinicaltrials.gov/study/NCT02993198","title":"A Prospective Study of Early Stage Breast Cancer Patients With Abnormal Myocardial Deformation Treated With Anthracycline and/or Trastuzumab and Pertuzumab-based Cancer Therapy","has_exemption":false,"start_date":"2015-04-30","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01906385","publication_url":"https://clinicaltrials.gov/study/NCT01906385","title":"A Dual Phase 1/2, Investigator Initiated Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of 186Rhenium Nanoliposomes (186RNL) in Recurrent Glioma (CTRC# 12-02)","has_exemption":false,"start_date":"2015-06-03","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Plus Therapeutics","sponsor_slug":"plus-therapeutics","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02420847","publication_url":"https://clinicaltrials.gov/study/NCT02420847","title":"A Phase I Two-Dimensional Dose-Finding Study of Ixazomib in Combination With Gemcitabine and Doxorubicin, Followed by a Phase II Extension to Assess the Efficacy of This Combination in Metastatic, Surgically Unresectable Urothelial Cancer","has_exemption":false,"start_date":"2015-07-03","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02583672","publication_url":"https://clinicaltrials.gov/study/NCT02583672","title":"Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1): Potential Use of Antioxidant/Anti-inflammatory Medications","has_exemption":false,"start_date":"2015-09-30","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02446093","publication_url":"https://clinicaltrials.gov/study/NCT02446093","title":"Neoadjuvant CAN-2409 Plus Prodrug in Combination With Chemoradiation or Stereotactic Body Radiation Therapy for Borderline Resectable Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2015-10-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Candel Therapeutics, Inc.","sponsor_slug":"candel-therapeutics-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02657551","publication_url":"https://clinicaltrials.gov/study/NCT02657551","title":"A Phase II Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer","has_exemption":false,"start_date":"2016-01-31","completion_date":"2025-12-31","has_results":true,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02677051","publication_url":"https://clinicaltrials.gov/study/NCT02677051","title":"Sulforaphane in Autism: A Treatment Trial to Confirm Phenotypic Improvement With Sulforaphane Treatment in a New Jersey (NJ) Population of Individuals With Autism","has_exemption":false,"start_date":"2016-02-29","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02691923","publication_url":"https://clinicaltrials.gov/study/NCT02691923","title":"Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker: Correlation With Preoperative MR, ALA-induced PpIX Fluorescence, and Histopathology","has_exemption":false,"start_date":"2016-03-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"David W. Roberts","sponsor_slug":"david-w-roberts","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03514784","publication_url":"https://clinicaltrials.gov/study/NCT03514784","title":"Road to Discovery for Combination Probiotic BB-12 With LGG (Different Doses) in Treating Autism Spectrum Disorder Disorders","has_exemption":false,"start_date":"2016-05-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02797275","publication_url":"https://clinicaltrials.gov/study/NCT02797275","title":"Lung Anatomic, Physiologic, and Inflammatory Changes With Chronic Exposure to Secondhand Tobacco Smoke","has_exemption":false,"start_date":"2016-06-06","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02734771","publication_url":"https://clinicaltrials.gov/study/NCT02734771","title":"Phase II Pilot Study of Brentuximab Vedotin, Rituximab and Dose Attenuated CHP in Elderly Patients With DLBCL","has_exemption":false,"start_date":"2016-06-30","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Patrick Reagan","sponsor_slug":"patrick-reagan","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02728388","publication_url":"https://clinicaltrials.gov/study/NCT02728388","title":"Topical Photodynamic Therapy (PDT) With Levulan® Kerastick® for Benign Dermal Neurofibromas Phase II","has_exemption":false,"start_date":"2016-08-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Donald Basel","sponsor_slug":"donald-basel","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03058835","publication_url":"https://clinicaltrials.gov/study/NCT03058835","title":"IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project","has_exemption":false,"start_date":"2016-09-30","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04205604","publication_url":"https://clinicaltrials.gov/study/NCT04205604","title":"18F-Fluoro-L- DOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism","has_exemption":false,"start_date":"2016-11-03","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Miguel Pampaloni","sponsor_slug":"miguel-pampaloni","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02986087","publication_url":"https://clinicaltrials.gov/study/NCT02986087","title":"Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia","has_exemption":false,"start_date":"2016-11-30","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03478215","publication_url":"https://clinicaltrials.gov/study/NCT03478215","title":"A Double-blind, Randomized, Controlled Dose Escalation Trial of Autologuous Mesenchymal Stromal Cells in Living Donor Kidney Transplant Recipients","has_exemption":false,"start_date":"2016-12-31","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT06409403","publication_url":"https://clinicaltrials.gov/study/NCT06409403","title":"Study on Clinical Application of Robotic Technique","has_exemption":false,"start_date":"2017-01-01","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"general surgery 3","sponsor_slug":"general-surgery-3","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03565913","publication_url":"https://clinicaltrials.gov/study/NCT03565913","title":"Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V","has_exemption":false,"start_date":"2017-01-22","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03218137","publication_url":"https://clinicaltrials.gov/study/NCT03218137","title":"Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions","has_exemption":false,"start_date":"2017-02-13","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02977715","publication_url":"https://clinicaltrials.gov/study/NCT02977715","title":"An Open-Label Prospective Cohort Study of JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo","has_exemption":false,"start_date":"2017-02-23","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Centers for Disease Control and Prevention","sponsor_slug":"centers-for-disease-control-and-prevention","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03091660","publication_url":"https://clinicaltrials.gov/study/NCT03091660","title":"S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2017-02-24","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03057964","publication_url":"https://clinicaltrials.gov/study/NCT03057964","title":"The Effect of Combined Treatment of PDL and Fractional Photothermolysis on the Cosmetic Appearance of Postsurgical Scars","has_exemption":false,"start_date":"2017-03-01","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03067051","publication_url":"https://clinicaltrials.gov/study/NCT03067051","title":"Open-label Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System (Interstitial Multiple Diode Lasers and IDOSE® Software) and Verteporfin for Injection (VFI) for the Treatment of Recurrent Prostate Cancer","has_exemption":false,"start_date":"2017-03-21","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"SpectraCure AB","sponsor_slug":"spectracure-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03125928","publication_url":"https://clinicaltrials.gov/study/NCT03125928","title":"Single Arm, Phase IIA Clinical Trial Assessing The Safety And Efficacy of Atezolizumab in Combination With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer","has_exemption":false,"start_date":"2017-06-13","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03193281","publication_url":"https://clinicaltrials.gov/study/NCT03193281","title":"KISS Study: A Phase II Study of Dasatinib Followed by Imatinib in Newly Diagnosed, Previously Untreated Patients With Chronic Phase CML","has_exemption":false,"start_date":"2017-07-17","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Auckland, New Zealand","sponsor_slug":"university-of-auckland-new-zealand","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03115333","publication_url":"https://clinicaltrials.gov/study/NCT03115333","title":"Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma","has_exemption":false,"start_date":"2017-07-25","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03272698","publication_url":"https://clinicaltrials.gov/study/NCT03272698","title":"A Prospective Randomized Controlled Trial of Electroconvulsive Therapy with Ketamine Anesthesia (Standard Therapy) and High Intensity Ketamine with Electroconvulsive Therapy Rescue for Treatment-Resistant Depression - EAST HIKER Trial","has_exemption":false,"start_date":"2017-09-01","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Saskatchewan","sponsor_slug":"university-of-saskatchewan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03127774","publication_url":"https://clinicaltrials.gov/study/NCT03127774","title":"Phase II Trial of Surgical Resection and Heated Intraperitoneal Peritoneal Chemotherapy (HIPEC) for Adrenocortical Carcinoma","has_exemption":false,"start_date":"2017-09-22","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03216005","publication_url":"https://clinicaltrials.gov/study/NCT03216005","title":"Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System","has_exemption":false,"start_date":"2017-11-02","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Intervene, Inc.","sponsor_slug":"intervene-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04095637","publication_url":"https://clinicaltrials.gov/study/NCT04095637","title":"A Prospective Randomised Control Trial of Mako Medial Unicondylar Knee Arthroplasty Versus Jig-based Oxford Unicompartmental Knee Arthroplasty With Navigation Contro","has_exemption":false,"start_date":"2017-11-24","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University College, London","sponsor_slug":"university-college-london","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03304821","publication_url":"https://clinicaltrials.gov/study/NCT03304821","title":"Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease: The GPAD-3 Study","has_exemption":false,"start_date":"2017-12-19","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03269669","publication_url":"https://clinicaltrials.gov/study/NCT03269669","title":"Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma","has_exemption":false,"start_date":"2018-01-23","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03384563","publication_url":"https://clinicaltrials.gov/study/NCT03384563","title":"Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane","has_exemption":false,"start_date":"2018-02-18","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03514108","publication_url":"https://clinicaltrials.gov/study/NCT03514108","title":"A Randomized, Double-blind, Placebo Controlled Study (DANHEART): Hydralazine-ISDN in Patients With Chronic Heart Failure - Hydralazine Heart Failure Trial (H-HeFT) and Metformin in Patients With Chronic Heart Failure and Diabetes or Insulin Resistance - Metformin Heart Failure Trial (Met-HeFT)","has_exemption":false,"start_date":"2018-03-01","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Henrik Wiggers","sponsor_slug":"henrik-wiggers","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03699995","publication_url":"https://clinicaltrials.gov/study/NCT03699995","title":"Imaging Modalities for Melanoma Screening and Diagnosis","has_exemption":false,"start_date":"2018-05-18","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03491761","publication_url":"https://clinicaltrials.gov/study/NCT03491761","title":"Does Intra-articular Platelet-Rich Plasma Injection Provide Superior Outcomes Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis?","has_exemption":false,"start_date":"2018-06-13","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Endeavor Health","sponsor_slug":"endeavor-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03504956","publication_url":"https://clinicaltrials.gov/study/NCT03504956","title":"Coronary Atherosclerosis T1-Weighted Characterization (CATCH)","has_exemption":false,"start_date":"2018-07-30","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03520374","publication_url":"https://clinicaltrials.gov/study/NCT03520374","title":"Evaluating the Effectiveness of a Self-instructional Ultrasound Training Program at Teaching Aspiration Risk Assessment Through Gastric Ultrasound","has_exemption":false,"start_date":"2018-08-02","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03601923","publication_url":"https://clinicaltrials.gov/study/NCT03601923","title":"Phase 2 Proof-of-Concept Trial Testing the PARP Inhibitor Niraparib in Patients With Pancreatic Cancer Harboring Deficiencies in Homologous Recombination DNA Repair","has_exemption":false,"start_date":"2018-08-22","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03626688","publication_url":"https://clinicaltrials.gov/study/NCT03626688","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH","has_exemption":false,"start_date":"2018-08-30","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"United Therapeutics","sponsor_slug":"united-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03582891","publication_url":"https://clinicaltrials.gov/study/NCT03582891","title":"Closed Loop Deep Brain Stimulation in Parkinson's Disease and Dystonia (Activa RC+S)","has_exemption":false,"start_date":"2018-10-01","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03586336","publication_url":"https://clinicaltrials.gov/study/NCT03586336","title":"Remote Dielectric Sensing Technology Guided Diuresis in Hospitalized Patients With Acute Decompensated Heart Failure","has_exemption":false,"start_date":"2018-12-01","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03792919","publication_url":"https://clinicaltrials.gov/study/NCT03792919","title":"Virological Response After Cessation of Long Term Anti-HBV Nucleos(t)Ide Analogues (NAs) vs. Keeping on NAs Among Chronic Hepatitis B (CHB) Patients","has_exemption":false,"start_date":"2018-12-01","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Humanity & Health Medical Group Limited","sponsor_slug":"humanity-health-medical-group-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03944447","publication_url":"https://clinicaltrials.gov/study/NCT03944447","title":"Outcomes Mandate National Integration With Cannabis as Medicine","has_exemption":false,"start_date":"2018-12-01","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"OMNI Medical Services, LLC","sponsor_slug":"omni-medical-services-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03670056","publication_url":"https://clinicaltrials.gov/study/NCT03670056","title":"A Pilot Study of Combination Immunotherapy With Ipilimumab and Nivolumab in Patients With Recurrent Extensive Stage Small Cell Lung Cancer (SCLC) Who Have Previously Received Platinum-based Chemotherapy","has_exemption":false,"start_date":"2018-12-06","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03513731","publication_url":"https://clinicaltrials.gov/study/NCT03513731","title":"Safety and Efficacy of Injection of Adipose-derived Regenerative Cells (ADRCs) in Patients Suffering From Osteoarthritis of the Facet Joints","has_exemption":false,"start_date":"2018-12-07","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"InGeneron, Inc.","sponsor_slug":"ingeneron-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03593759","publication_url":"https://clinicaltrials.gov/study/NCT03593759","title":"Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial","has_exemption":false,"start_date":"2019-01-15","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Ottawa Heart Institute Research Corporation","sponsor_slug":"ottawa-heart-institute-research-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03482479","publication_url":"https://clinicaltrials.gov/study/NCT03482479","title":"Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis","has_exemption":false,"start_date":"2019-02-04","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03856658","publication_url":"https://clinicaltrials.gov/study/NCT03856658","title":"A Phase II Trial of Hepatic Artery Infusional Floxuridine With Systemic Chemotherapy in the Treatment of Pancreatic Cancer Liver Metastases","has_exemption":false,"start_date":"2019-02-05","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Corewell Health West","sponsor_slug":"corewell-health-west","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03232918","publication_url":"https://clinicaltrials.gov/study/NCT03232918","title":"A Randomized Controlled Trial Evaluating the Effect of the Oxytocin Infusion Rate on Fetal Heart Rate Changes and Maternal-Fetal Outcomes During the Initiation of Combined Spinal-Epidural Labor Analgesia","has_exemption":false,"start_date":"2019-02-20","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Unyime Ituk","sponsor_slug":"unyime-ituk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04062565","publication_url":"https://clinicaltrials.gov/study/NCT04062565","title":"A Prospective Trial to Evaluate Up-front Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Patients With Advanced Pulmonary Arterial Hypertension (IIR-3810)","has_exemption":false,"start_date":"2019-03-25","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03711890","publication_url":"https://clinicaltrials.gov/study/NCT03711890","title":"Imaging and Detection of Micrometer Sized Early Stage Pancreatic Cancer by Using Endoscopic Ultra-High Resolution Optical Coherence Tomography (OCT) Using Resected Pancreatic Specimen, a Pilot Study","has_exemption":false,"start_date":"2019-03-26","completion_date":"2025-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null}]}